Curida
Elverum, Norway curida.no From their website, Nov 2026
- GMP
- ISO 9001
Work here? Claim this listing
About
Curida is a CDMO based in Norway that provides contract development and manufacturing for liquid pharmaceuticals and biologics. It serves pharmaceutical, diagnostic, pharmacy, cosmetic, and nutrition partners from sites in Elverum, Fornebu, and Ås.
Services
Nasal & Ophthalmic Solutions
End-to-end development and contract manufacturing of sterile and non-sterile liquid pharmaceuticals, including formulation, tech transfer, development, regulatory support, and analytical services.
Biologics & Diagnostic Solutions
Development, optimisation, manufacturing, purification, testing, and bioconjugation of monoclonal antibodies and related biologics.
Pharmacy Formulations
Small-scale manufacturing, formulation, fill-finish, and supply of pharmaceutical, cosmetic, and nutrition products for pharmacies and related clients.
Tech Transfer
Transfer of liquid products with support for manufacturing continuity, regulatory compliance, and supply chain readiness.
Development
Product development support from formulation and device selection through scale-up, registration batches, analytical method development, CMC documentation, and re-engineering.
Regulatory Expertise
Support for regulatory planning and ongoing commercial supply for liquid pharmaceutical products.
Lab / Analytical Services
In-house analytical and microbiological testing, including method development, stability studies, and batch release testing.
Antibody Development & Optimisation
Development and optimisation of monoclonal antibodies from discovery through clinical trials, including cell line testing.
5 more services
- Antibody Manufacturing
- Bioconjugation Services
- Formulation & Development
- Fill & Finish
- Specialised Pharmaceuticals
- Turnaround
- 2–3 weeks
Capabilities
- Assays and studies
- Antibodies
- Fill-finish
- Stability studies
- Analytical development
- Bioreactors
- Analytical testing
8 more
- Microbiological testing
- Method development
- Batch release testing
- Identity testing
- Potency testing
- Purity testing
- Cell line testing
- QC testing of cell banks
- Scale and capacity
- 3L and 50L stirred tank bioreactors
- 3 filling lines
- Batch sizes up to 800 liters
- 4 nasal spray production lines
- 90 million units annual nasal spray capacity
- 6 Blow-Fill-Seal lines
3 more
- 165 million units annual Blow-Fill-Seal capacity
- 10-30 ml bottle sizes
- 0.15 to 30 ml LDPE ampoules and bottles
- Therapeutic areas
- Ophthalmics
- Respiratory
- Injectables
- Wound care
- Upper respiratory
Instruments and platforms
- 3L stirred tank bioreactors
- 50L stirred tank bioreactors
- 96-well plates
- Affinity chromatography
- SEC
- TFF
Modalities and species
- Modalities
- Antibody
- ADC
- Species and models
- CHO cells
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 13485:2016Self-reported
Scope: Liquid Formulations site
ISO 9001:2015Self-reported
Scope: Biologics site
GMPSelf-reported
Scope: Liquid Formulation manufacturing
Details
- Type
- CDMO
- Founded
- 1987
- Based in
- Elverum, Norway
- Sites
- Fornebu, Norway
- Ås, Norway
- Serves
- Global, over 80 countries worldwide, Norway
Public records
- Parent company
- CURIDA HOLDING AS · NO GLEIF
- FDA establishment
- 3010814025